Clinical effect of one-time urinary catheter combined with resorcinol on cervical pretreatment before hysteroscopy
10.3760/cma.j.cn121361-20200214-00050
- VernacularTitle:一次性导尿管联合间苯三酚在宫腔镜术前宫颈预处理的临床效果
- Author:
Jun YIN
1
;
Jun YU
;
Juanrong LIU
Author Information
1. 江西省赣州市立医院妇产科 341000
- From:
Clinical Medicine of China
2020;36(6):544-547
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical effect of disposable urinary catheter combined with phloroglucinol in cervical pretreatment before hysteroscopy.Methods:From March 2018 to January 2020, 40 clinical data of patients with hysteroscopy in Ganzhou Municipal Hospital were prospectively analyzed, and they were randomly divided into control group and observation group, with 20 cases in each group.In the control group, carboprost suppository was placed in the posterior fornix of vagina 12 hours before hysteroscopy for cervical pretreatment, phloroglucinol was injected intravenously 30 minutes before operation to assist cervical dilatation; in the observation group, disposable catheter was inserted into the cervical tube 12-15 hours before hysteroscopy for dilation, and two gauzes were inserted into the vagina to prevent the catheter from falling off Phloroglucinol was injected intravenously to assist cervical dilatation.The degree of cervical softening and the effect of uterine dilatation were compared between the two groups, and the uterine dilatation time, operation time and intraoperative blood loss of the two groups were recorded.Results:The degree of cervical softening in the observation group was better than that in the control group ( Z=2.995, P=0.003); the cervical dilation time (15.56±3.14) s in the observation group was shorter than that in the control group (25.54±3.59) s ( t=4.653, P<0.001); the operation time (29.24±6.32) min is shorter than the control group (37.36±6.48) min ( t=4.012, P<0.001), the intraoperative blood loss (5.69±4.03) mL is lower than the control group (14.82±5.49) mL ( t=5.995, P<0.001); the incidence of adverse reactions in the observation group was 5.00% (1/20) slightly lower than the control group 30.00%(6/20) (χ 2=4.329, P=0.037). Conclusion:For patients undergoing hysteroscopic surgery, the use of disposable catheter combined with phloroglucinol for cervical pretreatment can fully soften the cervix, shorten the operation time, reduce intraoperative blood loss and reduce the incidence of adverse reactions.
